BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//wp-events-plugin.com//7.4.5//EN
TZID:America/Phoenix
X-WR-TIMEZONE:America/Phoenix
BEGIN:VEVENT
UID:2037@azbio.org
DTSTART;TZID=America/Phoenix:20261005T173000
DTEND;TZID=America/Phoenix:20261005T193000
DTSTAMP:20260807T135952Z
URL:https://www.azbio.org/events/leading-women-biotech-and-beyond-6
SUMMARY:Leading Women: Biotech and Beyond - 850 PBC - 5 Oct 26 17:30
DESCRIPTION:\nJoin us to kick off Arizona Bioscience Week in style!\nLeadin
 g Women: Biotech and Beyond\n\nJoin us for cocktails connections and stimu
 lating conversation with some of biotech’s leading women.&nbsp\; &nbsp\;
  &nbsp\;\n\nDate:&nbsp\; Monday\, October 5\, 2026\n\nTime:&nbsp\;&nbsp\;5
 :30PM – 7:30 PM\n\nLocation:&nbsp\;850 PBC&nbsp\;\n\n850 N 5th Street\, 
 Phoenix\, Arizona 85004\nAgenda:&nbsp\;&nbsp\;\n5:30 – Cocktails&nbsp\; 
 &amp\; Networking\n\n6:00 – Leading Women Panel&nbsp\;\n\nWelcome: Joan 
 Koerber-Walker &amp\; Scarlett Spring\n\n 	Dr. Karen Anderson\, Arizona St
 ate University\n 	Joan Koerber-Walker\, AZBio\n 	Anne Mazet\, Xcellerant V
 entures\n 	Stacey Stevens\, SimBioSys\n\n7:00&nbsp\; – Cocktails &amp\; 
 Networking\n\n7:30&nbsp\; – Event Concludes&nbsp\;\nTickets\nRegistratio
 n is complimentary for AZBio Members\, Elected Leaders\, and credentialed 
 Media.\n\nNon Members:&nbsp\; $50\n\nTo check if your company is an AZBio 
 Member\,&nbsp\;click here.\nRegister\nRegister Early - This event fills up
  fast!\nAbout Our Leading Women\n\n\n&nbsp\;\n\nDr. Karen Anderson&nbsp\;\
 n\n Professor in the School of Life Sciences at Arizona State University\n
 \nAssociate Dean of Research for the School of Medicine and Advanced Medic
 al Engineering.\n\n&nbsp\;\n\nDr. Karen Anderson is a tumor biologist and 
 Professor in the School of Life Sciences at Arizona State University\, whe
 re she also serves as the Associate Dean of Research for the School of Med
 icine and Advanced Medical Engineering. She earned both her M.D. and Ph.D.
  from Duke University. Dr. Anderson completed her clinical training in hem
 atology and oncology at Brigham and Women’s Hospital and Dana-Farber Can
 cer Institute\, and she is board-certified in both oncology and hematology
 . Dr. Anderson’s research focuses on harnessing the immune system to det
 ect and modify cancer development. Her team investigates the diversity and
  specificity of the adaptive immune response. Utilizing molecular techniqu
 es such as&nbsp\;nanopore&nbsp\;sequencing\, protein arrays\,&nbsp\;molecu
 lar modeling&nbsp\;and functional genomics\, her group explores the early 
 immune alterations associated with cancer to identify novel targets for tr
 eatment and vaccine development.\n\n\n\n&nbsp\;\n\nJoan Koerber-Walker\n\n
 President &amp\; CEO\, Arizona Bioindustry Association\n\nChairman\, Oppor
 tunity Through Entrepreneurship Foundation\n\n&nbsp\;\n\nAs President and 
 CEO of AZBio\, Joan Koerber-Walker works on behalf of the Arizona Bioscien
 ce and Medical Technology Industry to support the growth of the industry\,
  its members and our community on the local and national level. Joan is al
 so a life science investor and has served on the boards of numerous for-pr
 ofit and non-profit organizations. Over her career\, she has championed in
 novation in the halls of government and has worked with innovators on six 
 continents plus points in between.&nbsp\; (Joan's not a fan of cold weathe
 r and there is not a lot happening on that seventh continent.)&nbsp\;\n\n\
 n\n&nbsp\;\n\nAnne Mazet\n\nChief of Staff\n\nJET FUEL\, Xcellerant Ventur
 es &amp\; The Jetstream Venture Fund\n\n&nbsp\;\n\nAnne serves as Chief of
  Staff to Xcellerant Venture’s JET FUEL Team. JET FUEL is an elite group
  of experts who bring hands-on experience across technology\, go-to-market
  strategy\, finance\, and growth directly to Xcellerant Ventures and The J
 etstream Venture Fund’s founders and portfolio companies.&nbsp\;A vetera
 n of J.P. Morgan\, CNN\, Spectrum Science Communications and Moore Capital
  Management\, Anne brings deep expertise in organizational development and
  executive operations. She has a proven track record of managing high-perf
 orming teams and partnering with founders and executives to streamline ope
 rations and accelerate execution.&nbsp\;Anne holds a Bachelor of Science i
 n Communications and Journalism from Ithaca College\, and furthered her ed
 ucation at the New York Institute of Finance\, where she focused on the se
 curities industry and alternative investments.\n\n\n\n&nbsp\;\n\nStacey St
 evens\n\nPresident &amp\; CEO\n\nSimBioSys\n\n&nbsp\;\n\nStacey Stevens is
  a seasoned healthcare executive and strategic advisor with over two decad
 es of leadership experience driving innovation in medical technology\, onc
 ology\, and women’s health. She currently serves as President and CEO of
  SimBioSys\, where she is leading efforts to transform cancer care through
  advanced simulation and precision medicine. Stacey is also the Founding P
 artner of Ellevate\, a global strategic advisory firm accelerating the ado
 ption of scientific breakthroughs in women’s health\, where she has work
 ed with Fortune 100 companies and early-stage AI innovators in maternal he
 alth and oncology. In addition\, she advises Learn Look Locate\, supportin
 g global breast cancer awareness and patient advocacy initiatives. Previou
 sly\, Stacey spent nearly 17 years at iCAD\, where she served in multiple 
 executive roles\, including President and CEO\, and helped establish the c
 ompany as a leader in AI-powered cancer detection and therapy solutions. E
 arlier in her career\, she held senior leadership positions at Philips Hea
 lthcare and Hewlett-Packard\, spearheading global marketing and strategy i
 nitiatives across cardiac care and ultrasound.\n\n\n\n&nbsp\;\n\nScarlett 
 Spring\n\nExecutive Director of Phoenix Bioscience Core\n\nBoard Chair\, F
 ounder/CEO of TapRoot Interventions &amp\; Solutions\n\n&nbsp\;\n\nScarlet
 t Spring’s career began in big pharma\, where she worked for 20 years fo
 r companies like Merck and AstraZeneca\, helping to launch notable drugs s
 uch as Prilosec\, Nexium\, and Crestor. She later led AstraZeneca’s onco
 logy portfolio\, introducing treatments for lung\, breast\, and prostate c
 ancers. After moving to Phoenix\, she spent time at the Greater Phoenix Ec
 onomic Council (GPEC)\, gaining experience in economic development\, befor
 e returning to the entrepreneurial space leading a company focused on lung
  cancer diagnostics.&nbsp\;\n\n&nbsp\;\nSponsorships are available.&nbsp\;
 \n\n\nFor more information\,&nbsp\;contact AZBio.\nThank You Sponsors!\n&n
 bsp\; \n\n&nbsp\;\n\n
CATEGORIES:AZ - Central
LOCATION:850 PBC\, 850 N 5th Street\, Phoenix\, AZ\, 85004\, United States
X-APPLE-STRUCTURED-LOCATION;VALUE=URI;X-ADDRESS=850 N 5th Street\, Phoenix\
 , AZ\, 85004\, United States;X-APPLE-RADIUS=100;X-TITLE=850 PBC:geo:0,0
END:VEVENT
BEGIN:VTIMEZONE
TZID:America/Phoenix
X-LIC-LOCATION:America/Phoenix
BEGIN:STANDARD
DTSTART:20251005T173000
TZOFFSETFROM:-0700
TZOFFSETTO:-0700
TZNAME:MST
END:STANDARD
END:VTIMEZONE
END:VCALENDAR